Cingulate Inc. (CING)
Nasdaq: CING · Pharmaceutical Preparations · Kansas City, KS · filing with the SEC since 2021
Who owns Cingulate Inc.
As filed with the SECHolders of 5% or more
1
Falcon Creek Capital Advisor LLC holds 28.5% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Mar 26, 2026 says.
Directors and officers
10
report now, of 19 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Falcon Creek Capital Advisor LLC
SCHEDULE 13D/A · filed Mar 26, 2026 · Common Stock, par value $0.0001 per share · 19.9% in Feb 9, 2026
What CING reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
H.C. Wain Wright and Co LLC
An entity · legal entity · owns, named in the 10-K filed Mar 18, 2026
Streetville Capital LLC
An entity · legal entity · owns, named in the 10-K filed Mar 18, 2026
2 subsidiaries in 1 country, from the list filed with the 10-K filed Apr 1, 2024.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$700,000bought, in dollars
Open-market trades on Form 4 from Oct 2, 2025 to Oct 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Schaffer Shane J. | Chief Executive Officer | 0 | $0 | 0 | 1 | $0 |
| Callahan Jennifer L. | EVP and CFO | 0 | $0 | 0 | 1 | $0 |
| Brams Matthew | EVP and Chief Medical Officer | 0 | $0 | 0 | 1 | $0 |
| Hargroves Thomas Jeffrey | director | 0 | $0 | 0 | 1 | $500,000 |
| Werth Peter J. | director | 0 | $0 | 0 | 1 | $100,000 |